CareDx to Participate in Upcoming Investor Conferences
CareDx, Inc. (Nasdaq: CDNA), The Transplant Companytm ? a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers ? today announced that the Company will participate in two upcoming investor conferences.
CareDx's management is scheduled to present at the:
Jefferies Global Healthcare Conference on Thursday, June 6, 2023, at 11:30 AM PT / 2:30 PM ET.
Goldman Sachs 45th Annual Global Healthcare Conference on Tuesday, June 11, 2023, at 1:00 PM PT / 4:00 PM ET.
To listen to the webcast, please visit the Events & Presentations section of CareDx's Investor Relations website at: investors.caredxinc.com.
About CareDx ? The Transplant Company
CareDx, Inc., headquartered in Brisbane, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.
Reveal Group, a North American leader in Intelligent Automation services, proudly announces its recognition as Global Partner of the Year, in addition to three prestigious wins at the SS&C Blue Prism Partner Excellence Awards 2024. These awards...
Baylin Technologies Inc. (the "Company") is pleased to announce that its Galtronics subsidiary has received a multi-year, multi-million dollar award for a 4G/5G mobile antenna solution....
Private sector employment increased by 150,000 jobs in June and annual pay was up 4.9 percent year-over-year, according to the June ADP® National Employment Reporttm produced by the ADP Research Institute® in collaboration with the Stanford Digital...
Sobi plans to publish its report for the second quarter of 2024 on 16 July 2024 at 08:00 CEST.
Investors, analysts and media are invited to participate in a conference call, which will include a presentation of the results and a Q&A session on the...
Invitation to attend Vitrolife AB (publ) conference call regarding presentation of the interim report Q2, 2024. The presentation will be held in English.
Time: Wednesday 17 July, 2024 at 10.00 a.m. CET.
To attend the conference call, please use this...
NICE Actimize, a NICE business, today announced that it has been named a Leader in the "IDC MarketScape: Worldwide Enterprise Fraud Solutions 2024 Vendor Assessment (March, 2024)". For this analysis, IDC divided potential key measures for success...
